Oral, ultra-long-acting medication on the horizon

Single administration drugs may soon deliver sustained dosages over weeks, months or potentially even years, research suggests Researchers from Brigham and Women's Hospital and the Massachusetts Institute of Technology in the US have designed a capsule-carried dosage form that can deliver up to 10 to 14 days of sustained, mosquitocidal ivermectin. The design involves star-shaped,